BIO-key International, Inc. (NASDAQ:BKYI) Sees Large Increase in Short Interest

BIO-key International, Inc. (NASDAQ:BKYIGet Rating) saw a large increase in short interest during the month of April. As of April 30th, there was short interest totalling 138,900 shares, an increase of 121.9% from the April 15th total of 62,600 shares. Based on an average daily volume of 86,800 shares, the short-interest ratio is presently 1.6 days. Currently, 1.8% of the company’s stock are short sold.

BKYI opened at $1.95 on Friday. The business has a 50 day moving average price of $2.24 and a 200 day moving average price of $2.35. BIO-key International has a twelve month low of $1.87 and a twelve month high of $4.28. The firm has a market cap of $16.39 million, a P/E ratio of -3.10 and a beta of 0.86.

BIO-key International (NASDAQ:BKYIGet Rating) last posted its quarterly earnings data on Tuesday, March 29th. The technology company reported ($0.26) earnings per share for the quarter. BIO-key International had a negative net margin of 96.70% and a negative return on equity of 27.76%. The business had revenue of $0.94 million during the quarter.

A hedge fund recently raised its stake in BIO-key International stock. Geode Capital Management LLC lifted its position in BIO-key International, Inc. (NASDAQ:BKYIGet Rating) by 33.3% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 85,219 shares of the technology company’s stock after purchasing an additional 21,282 shares during the quarter. Geode Capital Management LLC owned 1.09% of BIO-key International worth $186,000 at the end of the most recent reporting period. Institutional investors own 6.92% of the company’s stock.

BIO-key International Company Profile (Get Rating)

BIO-key International, Inc develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, as well as windows device authentication through IAM platform.

Featured Stories

Receive News & Ratings for BIO-key International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BIO-key International and related companies with's FREE daily email newsletter.